Shwartzman reaction after human renal homotransplantation.
Journal: 1968/April - New England Journal of Medicine
ISSN: 0028-4793
Relations:
Content
Citations
(73)
References
(10)
Diseases
(2)
Conditions
(2)
Chemicals
(2)
Organisms
(1)
Processes
(1)
Anatomy
(2)
Similar articles
Articles by the same authors
Discussion board
N Engl J Med 278(12): 642-648

SHWARTZMAN REACTION AFTER HUMAN RENAL HOMOTRANSPLANTATION<sup>*</sup>

address reprint requests to Dr. Starzl at Veterans Administration Hospital, 1055 Clermont Street, Denver, Colorado 80220
From the Department of Surgery, University of Colorado School of Medicine and the Denver Veterans Administration Hospital, Denver, Colorado, the Department of Experimental Pathology. Scripps Clinic and Research Foundation, La Jolla, California, and the Department of Surgery, School of Medicine, University of California, Los Angeles

Abstract

In three human recipients, five renal homografts were destroyed within a few minutes to hours after their revascularization in the new host. The kidneys, removed one to 54 days later, had cortical necrosis. The major vessels were patent, but the arterioles and glomeruli were the site of fibrin deposition. There was little or no fixation of host immunoglobulins in the homografts. The findings were characteristic of a generalized Shwartzman reaction.

Although the cause (or causes) of the Shwartzman reaction in our patients is not known, they may have been conditioned by the bacterial contamination and hemolysis that often attend hemodialysis, by immunosuppression and by the transplantation itself. Some of the patients have preformed lymphocytotoxic antibodies. Thus, certain patients may be predisposed. High-risk patients should be recognized and treated prophylactically with anticoagulants.

Abstract

Recently, there have been several reports of “hyperacute rejection” after human renal homotransplantation. In some of these cases the homograft sustained an irreparable injury while the patient was still on the operating table.14 In cases in which major red-cell group compatibility existed between the donors and recipients, such a complication was not recognized in the first 180 cases of renal transplantation at the University of Colorado. Then, within an interval of six and a half weeks, five homografts were destroyed in three patients within minutes or hours after their revascularization.

It has been suggested24 that these immediate disasters were due to the direct cytotoxic action of preformed antibodies in the host that reacted against histocompatibility antigens present in the transplanted kidney. The state of advance sensitization to these specific antigens was presumably induced during the course of multiple pregnancies, by the previous administration of multiple blood transfusions or by other means such as prior renal homotransplantation. Where pathological reports were given, the morphologic consequence of the supposed acute antigen-antibody reactions included extensive destruction of the homograft vasculature.24

In the homografts of our own patients, the most striking finding was extensive intravascular deposition of fibrin, causing occlusion of most of the glomerular capillaries and consequent cortical necrosis exactly as occurs in the experimental generalized Shwartzman reaction.5 There was little or no host immunoglobulin deposition in the five kidneys removed 24 hours to eight weeks after transplantation.

Recognition that this complication may occur is important for several reasons. In the first place, experimental observations and the present clinical experience indicate that the Shwartzman reaction can be prevented and even in part reversed with appropriate anticoagulant or fibrinolytic therapy. Secondly, several factors that may contribute to its development can be eliminated or at least minimized by attention to details of preoperative care. Finally, the failure of function of a kidney involved in the Shwartzman reaction should not necessarily be attributed to a poor histocompatibility match since a variety of other immunologic and nonimmunologic factors may be contributory.

Footnotes

This is publication No. 261 from the Scripps Clinic and Research Foundation.

Footnotes

REFERENCES

REFERENCES

References

  • 1. Terasaki PI, Marchioro TH, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. Conference on Histocompatibility Testing, Washington, D. C, 1964. Histocompatibility testing: Report of a conference and workshop sponsored by the Division of Medical Sciences, National Academy of Sciences, National Research Council, 7–12 June, 1964. Conference on Histocompatibility Testing. Edited by P. S. Russell and H. J. Winn. Workshop on Histocompatibility Testing. Edited by D. B. Amos; National Research Council; Washington. D. C.. 1965. pp. 83–95. [PubMed]
  • 2. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg OHyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet. 1966;2:662–665.[PubMed][Google Scholar]
  • 3. Williams GM, et al Studies in hyperacute and chronic renal homograft rejection in man. Surgery. 1967;62:204–212.[PubMed][Google Scholar]
  • 4. Williams GM, Hume DM, Kano K, Milgrom F. Personal communication [PubMed]
  • 5. Lee L, Stetson CA. Local and generalized Shwartzman phenomena. In: Zwei-fach BW, Grant L, McCluskey RT, editors. The Inflammatory Process. New York: Academic Press; 1965. pp. 791–817. [PubMed]
  • 6. Terasaki PI, Vredevoe DL, Mickey MR. Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation. 1967;5:1057–1070.[PubMed]
  • 7. Starzl TE, Porter KA, lwasaki Y, Marchioro TL, Kashiwagi N. Use of antilymphocyte globulin in human renal homotransplantation. In: Wolstenholme GEW, O’Connor MJ, editors. Ciba Foundation. Antilymphocytic Serum (by) Study Group No. 9. London: Churchill; 1967. pp. 4–34. [PubMed]
  • 8. Lerner RA, Glassock RJ, Dixon FJRole of antiglomerular basement membrane antibody in pathogenesis of human glomerulonephritis. J. Exper. Med. 1967;126:989–1004.[Google Scholar]
  • 9. Hjort PF, Rapaport SIShwartzman reaction: pathogenetic mechanisms and clinical manifestations. Ann. Rev. Med. 1965;16:135–168.[PubMed][Google Scholar]
  • 10. Brown E, Seidel W, Kolff WJHemolysis caused by pumps at flow rates of 2 liters. Tr. Am. Soc. Artif. Int. Organs. 1961;7:350–354.[PubMed][Google Scholar]
  • 11. von Kaulla KN, von Kaulla E, Wasantapruck S, Marchioro TL, Starzl TEBlood coagulation in uremic patients before and after hemodialysis and transplantation of kidney. Arch. Surg. 1966;92:184–191.[Google Scholar]
  • 12. Sherris JC, Cole JJ, Scribner BHBacteriology of continuous flow hemodialysis. Tr. Am. Soc. Artif. Int. Organs. 1961;7:37–40.[PubMed][Google Scholar]
  • 13. Kidd EEBacterial contamination of dialyzing fluid of artificial kidney. Brit. M.J. 1964;1:880–882.[Google Scholar]
  • 14. Lewis DH, et al Value of renal blood flow measurement with xenon-133 at time of kidney transplantation. Ann. Surg. 1967;166:65–74.[Google Scholar]
  • 15. Thomas L, Good RAEffect of cortisone on Shwartzman reaction. J. Exper. Med. 1952;95:409–427.[Google Scholar]
  • 16. Kashiwagi N, Brantigan CO, Brettschneider L, Groth CG, Starzl TEClinical reactions and serologic changes following administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann. Int. Med. (in press)
  • 17. Merrill JP. Personal communication [PubMed]
  • 18. Arhelger RB, Brunson JG, Good RA, Vernier RLInfluence of gram-negative endotoxin on pathogenesis of nephrotoxic serum nephritis in rats. Lab. Investigation. 1961;10:669–687.[PubMed][Google Scholar]
  • 19. Terasaki PI, Trasher DL, Hauber TH Advance in Transplantation. Copenhagen: Munksgaard; 1968. Serotyping for homotransplantation. XIII. Immediate kidney transplant rejection and associated preformed antibodies; pp. 225–229. [PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.